Literature DB >> 22299427

Knowledge and practice of travel medicine among primary health care physicians in Qatar.

Mohammed Al-Hajri1, Abdulbari Bener, Omar Balbaid, Ezaeldin Eljack.   

Abstract

This prospective descriptive survey was conducted among primary health care (PHC) physicians in Qatar from January to May 2007 in order to determine whether travelers obtained correct travel health information. Of 130 physicians approached, 98 agreed to participate in the study and 76 attended the symposium and complete the questionnaire. The questionnaire included sociodemographic characteristics, knowledge and practices about travel medicine before and after the symposium. Forty-four point seven percent of the subjects provided health advice to travelers. Female physicians (59.2%) outnumbered male physicians (40.8%). Qatari physicians (60.5%) outnumbered non-Qataris (39.5%). Most physicians spent at least 15 minutes with each traveler (44.1%). The symposium increased the knowledge of physicians about travel medicine. A significant increase in knowledge was seen in the post-symposium questionnaire for most questions. The main source of knowledge for most physicians was the internet (78.9%). Nearly half the subjects provided pre-travel health advice. All the subjects had improved knowledge of travel medicine following the symposium.

Mesh:

Year:  2011        PMID: 22299427

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  2 in total

1.  The Knowledge and Uptake of Travel Vaccine Among Medical Doctors in a Tertiary Health Institution in Plateau State, North Central Nigeria.

Authors:  Zuwaira Ibrahim Hassan; Tolulope O Afolaranmi
Journal:  Indian J Community Med       Date:  2015 Jul-Sep

2.  Primary care physicians' knowledge of travel vaccine and malaria chemoprophylaxis and associated predictors in Qatar.

Authors:  Ayman Al-Dahshan; Nagah Selim; Noora Al-Kubaisi; Ziyad Mahfoud; Vahe Kehyayan
Journal:  PLoS One       Date:  2022-03-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.